Mon, October 11, 2021
Sun, October 10, 2021
Fri, October 8, 2021
Thu, October 7, 2021
Wed, October 6, 2021
Tue, October 5, 2021
Mon, October 4, 2021
Sun, October 3, 2021
Fri, October 1, 2021
Thu, September 30, 2021
Wed, September 29, 2021
Tue, September 28, 2021
Mon, September 27, 2021
Sun, September 26, 2021
Fri, September 24, 2021

Mani Foroohar Maintained (BBIO) at Buy with Increased Target to $68 on, Oct 4th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-68-on-oct-4th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Mani Foroohar of SVB Leerink, Maintained "BridgeBio Pharma, Inc." (BBIO) at Buy with Increased Target from $66 to $68 on, Oct 4th, 2021.

Mani has made no other calls on BBIO in the last 4 months.



There is 1 other peer that has a rating on BBIO. Out of the 1 peers that are also analyzing BBIO, 0 agree with Mani's Rating of Hold.



This is the rating of the analyst that currently disagrees with Mani


  • Geoff Meacham of "B of A Securities" Upgraded from Hold to Strong Buy and Held Target at $75 on, Friday, September 10th, 2021

Publication Contributing Sources